Atricure Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Atricure Inc in the third quarter 2026?
Atricure Inc achieved a return on average equity (ROE) of 2.93 % in its third quarter 2026, this is above ATRC's average return on equity of -14.04%.
Atricure Inc shareholder's equity over the 12 months ending in its third quarter 2026 are valued at $508 million

While the company's net income was fading, Atricure Inc was able to improve its ROE compared to the second quarter 2026.

Within the Medical Equipment & Supplies industry 60 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 2303 to 2383.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	11.9 %	11.18 %	8.15 %	6.72 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	15	11	-5	-11	-29
Return On Equity (TTM)	2.93 %	2.14 %	-0.95 %	-2.43 %	-6.2 %
ATRC's Total Ranking	# 2383	# 2303	# 1150	# 2225	#
Equity (TTM) in Millions	533	516	492	492	477
Seq. Equity Change	3.25 %	5.03 %	-0.05 %	3.24 %	2.59 %
Seq. Net Income Change	-54.62 %	8191.67 %	-93.85 %	-	-

Back to ATRC Management Effectiveness >> ATRC's 5 Years Annual ROE >> Compare ATRC ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 61
Sector	# 180
Overall	# 2383

Return On Equity Statistics
High	Average	Low
11.48 %	-14.04 %	-54.15 %
(Dec 31 2021)		(Dec 31 2012)

ATRC Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	492	461	466	457	484
Y / Y Equity Change	6.72 %	-1.12 %	2.06 %	-5.58 %	17.3 %
Net Income in Millions	-11	-45	-30	-46	50
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-2.33 %	-9.7 %	-6.53 %	-10.17 %	10.38 %

Back to ATRC Management Effectiveness >> ATRC's 5 Years Annual ROE >> Compare ATRC ROE to its Competitors

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ATRC's' Return on Equity at Yahoo Finance
ATRC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ATRC's Competitors
Subscribers only: Roe for Atricure Inc 's Suppliers
Subscribers only: Return On Equity for ATRC's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Incyte Corporation	7.08 %
Conmed Corporation	7.07 %
Teva Pharmaceutical Industries Limited	6.37 %
Integer Holdings Corporation	6.02 %
Avantor Inc	5.96 %
Ligand Pharmaceuticals Incorporated	5.22 %
Lifestance Health Group Inc	4.82 %
Jazz Pharmaceuticals Plc	4.62 %
Pfizer Inc	4.62 %
Innovage Holding Corp	4.52 %
Icu Medical Inc	2.81 %
Biogen Inc	1.86 %
Integra Lifesciences Holdings Corp	1.24 %

Date modified: 2026-11-06T12:57:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.